K. Sylvester (Cambridge (Cambridgeshire), United Kingdom), A. McGowan (Dublin 15, Ireland)
Introduction
K. Sylvester (Cambridge (Cambridgeshire), United Kingdom), A. McGowan (Dublin 15, Ireland)
|  |
Evaluation of covid-19 lung involvement effect on exercise capacity in the 3rd and 6th months
E. Yilmazel Uçar (Erzurum, Turkey), O. Araz (Erzurum, Turkey), B. Kerget (Erzurum, Turkey), K. Ozmen (Erzurum, Turkey), M. Akgun (Erzurum, Turkey), L. Saglam (Erzurum, Turkey)
|  |
Transition to a physiologist led cardiopulmonary exercise testing (CPET) service and evaluation of one year outcomes
S. Mcarthur (Edinburgh (Edinburgh), United Kingdom), J. Macleod (Edinburgh (Edinburgh), United Kingdom), S. Baxter (Edinburgh (Edinburgh), United Kingdom), K. Cuthbert (Edinburgh (Edinburgh), United Kingdom)
|   |
Comparing peripheral capillary oxygen saturation during a six-minute walk test with arterial saturation during a cardiopulmonary exercise test
L. Vesteng (Jessheim, Norway), C. Karlsen (Jessheim, Norway), A. Grongstad (Jessheim, Norway)
| |
NICE asthma guidelines: time to re-evaluate the diagnostic value of exercise challenge testing?
A. Simpson (Hull, United Kingdom), O. Price (Hull, United Kingdom)
| |
The role of transcutaneous carbon dioxide measurement during exercise.
R. Ong-Salvador (Amsterdam, Netherlands), P. Jak (Amsterdam, Netherlands), R. Bekkema (Amsterdam, Netherlands), J. Van Den Aardweg (Amsterdam, Netherlands)
| |
Effects of tidal expiratory flow limitation on lung functions, exercise limitation and symptoms severity in stable COPD
A. Rath (Raipur, India), V. Kumar (Raipur, India), D. Sahu (Raipur, India), S. De (Raipur, India)
| |
Recovery after histamine provocation: predictive power of gender and body mass index
C. de Vreede (Delft, Netherlands)
| |
Methacholine challenge: Safety of the quadrupling protocol
I. Steenbruggen (Zwolle, Netherlands), P. De Laat (Meppel, Netherlands)
| |
Cardiopulmonary exercise test & risk assessment in lung resection surgery: A Tunisian experience
N. Ben Salah (La Marsa, Tunisia), H. Mrassi (La Marsa, Tunisia), H. Blibech (La Marsa, Tunisia), H. Snene (La Marsa, Tunisia), M. Abdennadher (Ariana, Tunisia), L. Kaabi (La Marsa, Tunisia), S. Debbiche (La Marsa, Tunisia), N. Mehiri (La Marsa, Tunisia), T. Mestiri (Ariana, Tunisia), A. Marghli (Ariana, Tunisia), B. Louzir (La Marsa, Tunisia)
| |
Late Breaking Abstract - Adopting the 2019 ATS/ERS spirometry guidelines in clinical trials: impact on site and patient burden.
P. Lake (Monmouth, United Kingdom), K. McCarthy (Matthews, United States), D. Patterson (Philadelphia, United States), M. Baumle (Wurzburg, Germany), R. Farienfar (Wurzburg, Germany), J. Ramos (Cleveland, United States)
| |